Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.

Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company”), a clinical-stage macrophage reprogramming immunotherapy company, ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

in patients with active psoriatic arthritis (PsA). PsA is a chronic, debilitating and progressive inflammatory condition that ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has announced the successful dosing of the first patient in a Phase I trial to test ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Discover how global recruitment trends influence placebo response rates in Psoriatic Arthritis trials, revealing critical ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...